Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
MSH3 (MutS Homolog 3)
i
Other names:
MSH3, MutS Homolog 3, Divergent Upstream Protein, Mismatch Repair Protein 1, DNA Mismatch Repair Protein Msh3, HMSH3, MRP1, DUP, Epididymis Secretory Sperm Binding Protein, MutS (E. Coli) Homolog 3, MutS Homolog 3 (E. Coli), FAP4, DUC1, DUG
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4437
Related tests:
‹
Archer™ VARIANTPlex™ Pan Solid Tumor panel
BROCA Cancer Risk Panel
CancerNext ®
CancerNext-Expanded®
ColoNext®
ColoSeq™
CustomNext-Cancer®
GALEAS™ Hereditary Plus
Invitae Common Hereditary Cancers Panel
Labcorp® Plasma Complete™
Myriad myRisk® Hereditary Cancer
OptiSeq™ Colorectal Cancer Panel
Tempus xF Assay
Tempus xG+
Archer™ VARIANTPlex™ Pan Solid Tumor panel
BROCA Cancer Risk Panel
CancerNext ®
CancerNext-Expanded®
ColoNext®
ColoSeq™
CustomNext-Cancer®
GALEAS™ Hereditary Plus
Invitae Common Hereditary Cancers Panel
Labcorp® Plasma Complete™
Myriad myRisk® Hereditary Cancer
OptiSeq™ Colorectal Cancer Panel
Tempus xF Assay
Tempus xG+
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
MSH3 overexpression
Soft Tissue Sarcoma
MSH3 overexpression
Soft Tissue Sarcoma
ifosfamide + epirubicin
Resistant: B - Late Trials
ifosfamide + epirubicin
Resistant
:
B
ifosfamide + epirubicin
Resistant: B - Late Trials
ifosfamide + epirubicin
Resistant
:
B
MSH3 mutation
Gastric Cancer
MSH3 mutation
Gastric Cancer
durvalumab
Sensitive: C2 – Inclusion Criteria
durvalumab
Sensitive
:
C2
durvalumab
Sensitive: C2 – Inclusion Criteria
durvalumab
Sensitive
:
C2
MSH3 mutation
Gastric Cancer
MSH3 mutation
Gastric Cancer
tremelimumab-actl
Sensitive: C2 – Inclusion Criteria
tremelimumab-actl
Sensitive
:
C2
tremelimumab-actl
Sensitive: C2 – Inclusion Criteria
tremelimumab-actl
Sensitive
:
C2
MSH3 mutation
Colorectal Cancer
MSH3 mutation
Colorectal Cancer
PARP inhibitor
Resistant: D – Preclinical
PARP inhibitor
Resistant
:
D
PARP inhibitor
Resistant: D – Preclinical
PARP inhibitor
Resistant
:
D
MSH3 mutation
Colorectal Cancer
MSH3 mutation
Colorectal Cancer
KU-0060648
Sensitive: D – Preclinical
KU-0060648
Sensitive
:
D
KU-0060648
Sensitive: D – Preclinical
KU-0060648
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.